Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial 30S ribosomal subunit P-site (peptidyl site) is a fundamental functional domain within the small ribosomal subunit (30S) that plays a vital role in protein biosynthesis (Schmeing & Ramakrishnan, 2009, Nature). It is the site where the initiator tRNA (fMet-tRNA) binds during the formation of the translation initiation complex and where the peptidyl-tRNA resides after translocation during the elongation phase (Wilson, 2014, Nature Reviews Microbiology). The P-site is primarily formed by conserved nucleotides of the 16S ribosomal RNA (rRNA) and specific ribosomal proteins like S9, S12, and S13, ensuring the correct positioning of the mRNA codon and the corresponding tRNA anticodon (Yusupov et al., 2001, Science). Many clinically significant antibiotics exert their antimicrobial effects by targeting the 30S subunit, with some specifically obstructing the P-site to prevent the initiation of translation or to induce lethal misreading of the genetic code (McCoy et al., 2011, Journal of Molecular Biology). For example, drugs like kasugamycin and pactamycin interact with this region to inhibit bacterial growth, making it a key target for treating various infectious diseases (Schluenzen et al., 2006, Nature Structural & Molecular Biology). Streptomycin also binds in close proximity to this site, interfering with the decoding process and the stability of the P-site tRNA (Carter et al., 2000, Nature). However, the effectiveness of drugs targeting this site is frequently compromised by bacterial resistance mechanisms, such as the methylation of 16S rRNA by Rmt or Arm methyltransferases or mutations in ribosomal proteins that decrease drug affinity (Doi & Arakawa, 2007, Emerging Infectious Diseases).
Inhibition of translation initiation by blocking initiator tRNA binding to the P-site, or interference with the translocation process during elongation (Wilson, 2014, Nature Reviews Microbiology).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial 30S ribosomal subunit peptidyl-tRNA site (P-site) (30S P-site).